Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.

Neurosurgery - 1 Feb 2013

Vettukattil Riyas, Gulati Michel, Sjøbakk Torill E, Jakola Asgeir S, Kvernmo Nadja A M, Torp Sverre H, Bathen Tone F, Gulati Sasha, Gribbestad Ingrid S

Abstract excerpt

BACKGROUND: The prognosis and treatment of astrocytomas, which are primary brain tumors, vary depending on the grade of the tumor, necessitating a precise preoperative classification. Magnetic resonance spectroscopy (MRS) provides information about metabolites in tissues and is an emerging noninvasive tool to improve diagnostic accuracy in patients with intracranial neoplasia. OBJECTIVE: To investigate whether ex...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspartic Acid
Share to Astrocytoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Choline

Share to Creatine

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Spectroscopy

Share to Principal Component Analysis

Share to World Health Organization

Source

Identifiers

PMID: 23147779
DOI: 10.1227/NEU.0b013e31827b9c57

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.PMID 23147779Read ↗

Characterization of metabolites in infiltrating gliomas using ex vivo1H high‐resolution magic angle spinning spectroscopySemantic proximity Read ↗

Proton MR spectroscopy shows improved performance to segregate high-grade astrocytoma subgroups when defined with the new 2021 World Health Organization classification of central nervous system tumors.Semantic proximity Read ↗

MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classification.Semantic proximity Read ↗

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.Semantic proximity Read ↗

Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile.Semantic proximity Read ↗

Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas.Semantic proximity Read ↗

The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.Semantic proximity Read ↗

MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.Semantic proximity Read ↗

Metabolic Aggressiveness in Benign Meningiomas with Chromosomal InstabilitiesSemantic proximity Read ↗

Altered Amino Acid Metabolism in Glioma: In vivo MR-spectroscopic Detection of Alanine as a Potential Biomarker of Poor Survival in Glioma PatientsSemantic proximity Read ↗

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients.Semantic proximity Read ↗

Preoperative Determination of Isocitrate Dehydrogenase Mutation in Gliomas Using Spectral Editing MRS: A Prospective Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.